Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial-Reference-Cited by-同舟云学术

Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial

Published:2017-05 Issue:5 Volume:28 Page:1078-1083
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Besse B.,Mazières J.,Ribassin-Majed L.,Barlesi F.,Bennouna J.,Gervais R.,Moreau L.,Berard H.,Debieuvre D.,Molinier O.,Moro-Sibilot D.,Souquet P.J.,Jacquot S.,Petit L.,Lena H.,Pignon J.P.,Lacas B.,Morin F.,Milleron B.,Zalcman G.,Soria J.C.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/5/1078/13942912/mdx070.pdf

Reference19 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours;Goldstraw;J Thorac Oncol,2007

3. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up;Vansteenkiste;Ann Oncol,2014

4. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data;Arriagada;Lancet,2010

5. Phase I trial of pazopanib in patients with advanced cancer;Hurwitz;Clin Cancer Res,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung Cancer Clinical Trials with a Seamless Phase II/III Design: Systematic Review;Journal of Clinical Medicine;2022-12-02

2. Renal adverse reactions of tyrosine kinase inhibitors in the treatment of tumours: A Bayesian network meta-analysis;Frontiers in Pharmacology;2022-11-03

3. Les traitements péri-opératoires des cancers bronchiques non à petites cellules (CNPC) : standards actuels et perspectives;Revue des Maladies Respiratoires Actualités;2022-10

4. Prise en charge chirurgicale des cancers bronchiques non à petites cellules de stade localisé : voie d’abord et étendue de la résection;Revue des Maladies Respiratoires Actualités;2022-10

5. Integration of New Systemic Adjuvant Therapies for Non-small Cell Lung Cancer: Role of the Surgeon;The Annals of Thoracic Surgery;2022-09